# OnCo record idea-prev-prostate-as-triggered-biopsy (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-prev-prostate-as-triggered-biopsy/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-prev-prostate-as-triggered-biopsy" ;
  schema:name "Prostate active surveillance without scheduled biopsies: MRI and blood tests decide"@en ;
  schema:description "Men on active surveillance for prostate cancer have repeat biopsies every year or two, a burden that drives some towards surgery. Triggering biopsy only when MRI, PSA density or new markers change, tested against scheduled biopsy in a 2,000-man non-inferiority trial, could be just as safe with far fewer biopsies."@en ;
  schema:url <https://onco.cc/ideas/idea-prev-prostate-as-triggered-biopsy/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1093/jnci/djq099> ;
  onco:related <https://onco.cc/roadmaps/prostate-roadmap/>, <https://onco.cc/ideas/idea-prostate-per-lesion-mri-audit-before-focal-treatment/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:terms <https://onco.cc/terms/pi-rads/>, <https://onco.cc/terms/template-mapping-biopsy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-welch-j-natl-cancer-inst/> .